Clinical trials
Essential Hypertension trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Daiichi Sankyo | 1 |
| GlaxoSmithKline | 1 |
| National Taiwan University Hospital Hsin-Chu Branch | 1 |
| Pfizer | 1 |
| TSH Biopharm Corporation Limited | 1 |
| Takeda | 1 |
| Tri-Service General Hospital (TSGH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 12 |
| Hypertension | 5 |
| Diabetes Mellitus, Type 2 | 1 |
| Masked Hypertension | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.